Historic Total Current Liabilities for Nuvation Bio (NUVB) over the last 4 years, with Jun 2025 value amounting to $66.4 million.
- Nuvation Bio's Total Current Liabilities rose 29.87% to $66.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $66.4 million, marking a year-over-year increase of 29.87%. This contributed to the annual value of $58.2 million for FY2024, which is 316.80% up from last year.
- According to the latest figures from Q2 2025, Nuvation Bio's Total Current Liabilities is $66.4 million, which was up 25.74% from $52.8 million recorded in Q1 2025.
- In the past 5 years, Nuvation Bio's Total Current Liabilities registered a high of $66.4 million during Q2 2025, and its lowest value of $10.0 million during Q1 2021.
- Over the past 3 years, Nuvation Bio's median Total Current Liabilities value was $33.6 million (recorded in 2023), while the average stood at $35.9 million.
- As far as peak fluctuations go, Nuvation Bio's Total Current Liabilities skyrocketed by 6,758.58% in 2021, and later crashed by 41.46% in 2023.
- Nuvation Bio's Total Current Liabilities (Quarterly) stood at $13.3 million in 2021, then increased by 5.28% to $14.0 million in 2022, then climbed by 15.22% to $16.1 million in 2023, then skyrocketed by 265.70% to $59.0 million in 2024, then climbed by 29.87% to $66.4 million in 2025.
- Its last three reported values are $66.4 million in Q2 2025, $52.8 million for Q1 2025, and $59.0 million during Q3 2024.
